September 16:  9:00 am – 4:30 pm

Purpose
Both the cost and the likelihood of China global drug development teams encountering communications problems are high.  Project and cultural complexities make it difficult for drug development teams to perform and communicate at optimal levels.  Project team members often come from several different countries and organizations, all with their own cultures, assumptions and methods. 

The purpose of this seminar is to enable participants to improve global team management and communications in their own drug development project teams.    The program focuses in particular on strengthening partnering relationships among pharmaceutical companies and the Contract Research Organizations (CROs).  Chinese drug development global team success depends as much on effective management and communications as it does on excellent science and technology. 

Seminar Goals

Participants acquire in-depth understanding, cutting-edge strategies and practical skills to improve management and performance in their own China global drug development project teams.  The seminar provides a clear methodology for improving project alignment and communications, and achieving excellent partnering performance among diverse project participants and organizations.

Seminar Format

The seminar uses multiple real case examples in a dynamic learning environment.  Participants apply seminar strategies and tools to their own projects.  Participants leave the seminar with specific plans for improving their own projects.  

• Participants Learn:
  Predictable team communications problems to anticipate and avoid
  Chinese multi-cultural teams’ opportunities and blind spots
  What “partnering” really means, and the difference between partnering intentions and partnering methodology
  Partnering issues and opportunities within and between pharmaceutical companies and Contract Research Organizations (CROs)
  Partnering strategies and methods to strengthen pharmaceutical company – CRO team performance and communications
  Why and how to achieve full alignment among the diverse “silo” organizations working on a drug development projects
  How to address and resolve the classic project tensions among drug development, safety, regulatory and commercial/business development
  How to drive partnering intentions from top management throughout all project staff
  How to move beyond a reactive, problem-focused stance to more effective, proactive team management, innovation and optimal performance
  ­­­­­­­­­­­­­­­
  Click here for agenda